Mythri Shankar ๐Ÿ‡ฎ๐Ÿ‡ณ
6,247 posts
Image
user avatar
Mythri Shankar ๐Ÿ‡ฎ๐Ÿ‡ณ
@nephromythri
Assoc Prof, Nephrology, Institute of Nephrourology| PD-@NSMCinternship| @ISNkidneycare| @Glomcon instructor| @WIN-India|VA Editor- @KIReports, @kidneymedicine
Bengaluru, India
drmythrishankar.com
Joined June 2017
1,191
Following
4,639
Followers
  • Pinned
    user avatar
    Mythri Shankar ๐Ÿ‡ฎ๐Ÿ‡ณ
    @nephromythri
    Dec 26, 2025
    Ending the year on a positive note โœจ with the National Young Academic Excellence Award ๐Ÿ… conferred by the Indian Medical Association at 100th NATCON 2025. It was indeed an honour to receive this award from Dr Mukesh Mahaling, the Honourable Health Minister of Odisha ๐Ÿ™.
    Image
    Image
    Image
    Image
    2.2K
  • user avatar
    Mythri Shankar ๐Ÿ‡ฎ๐Ÿ‡ณ
    @nephromythri
    Jan 29, 2022
    Here is the clear version of "Approach to hypokalemia". #ecneph
    Image
  • user avatar
    Mythri Shankar ๐Ÿ‡ฎ๐Ÿ‡ณ
    @nephromythri
    Jun 20, 2024
    ๐Ÿ‘‡๐Ÿผ๐Ÿ“œCriteria for SIADH ๐Ÿ’ฆEuvolaemia ๐Ÿง‚serum sodium <130ย mmol/L โฌ‡๏ธserum osmolality <275ย mosm/kg ๐Ÿ’ฆUrine osmolality >100ย mosm/kg ๐Ÿง‚Urine Na typically >30ย mmol/L ๐Ÿ’ฆNo recent diuretic use ๐ŸฉธNormal adrenal and thyroid function Approach to hyponatremia ๐Ÿ‘‡๐Ÿผ #Nephpearls
    Image
    21K
  • user avatar
    Mythri Shankar ๐Ÿ‡ฎ๐Ÿ‡ณ
    @nephromythri
    Feb 4, 2023
    ๐Ÿ™Thank you for providing me the opportunity to write a mini-review on -"SGLT2 inhibitors & CKD " with such a great team! @poyanmehr @edgarvlermamd @NWiegley @nephrologik !!๐ŸŽ‰๐ŸŽŠ Checkout our paper๐Ÿ‘‰: kidneymedicinejournal.org/article/S2590-โ€ฆ
    Image
    Image
    Image
    Image
    24K
  • user avatar
    Mythri Shankar ๐Ÿ‡ฎ๐Ÿ‡ณ
    @nephromythri
    Apr 10, 2021
    Lets step into the new era of SGLT2 inhibitors!! #sglt2inhibitors "Six Simple Steps for SGLT2 Inhibitors!" Thank you @NSMCInternship @Nephro_Sparks @whatsthegfr @sophia_kidney @DTomacruzMD @CTeodosiu & Team beanpod!
    Image
  • user avatar
    Mythri Shankar ๐Ÿ‡ฎ๐Ÿ‡ณ
    @nephromythri
    Dec 12, 2021
    Awards are an encouragement. Iโ€™m beyond blessed and humbled to be awarded CJASN best visual abstract of the year!! Forever grateful to my mentors @NSMCInternship @Nephro_Sparks @kidney_boy @whatsthegfr @hswapnil @sophia_kidney !!๐Ÿ™๐Ÿป๐Ÿ™๐Ÿป๐Ÿ˜Š๐Ÿ˜Š
    Image
  • user avatar
    Mythri Shankar ๐Ÿ‡ฎ๐Ÿ‡ณ
    @nephromythri
    Nov 5, 2022
    Wow!!! This comes as a pleasant surprise!! Thank you so much dear #Nephjc team!!! Loads of love โค๏ธ โค๏ธ from India!!!
    user avatar
    Swapnil Hiremath @hswapnil.medsky.social
    @hswapnil
    Nov 5, 2022
    Replying to @hswapnil
    The #NephJCKidneys Founders award is a special award instituted in 2021, with @whatsthegfr being the inaugural awardee This year it was awarded to @nephromythri #KidneyWk
    Image
  • user avatar
    Mythri Shankar ๐Ÿ‡ฎ๐Ÿ‡ณ
    @nephromythri
    Apr 20, 2021
    Vaccines are a simple yet effective way of protecting CKD patients from harmful infections prior to txp. If missed prior to kidney txp, itโ€™s never too late to protect them post-transplant. Here are the vaccination recommendations prior to and post txp. โ€œLETโ€™S SHIELDโ€.๐Ÿ›ก๏ธ๐Ÿ›ก๏ธ
    Image
    Image
  • user avatar
    Mythri Shankar ๐Ÿ‡ฎ๐Ÿ‡ณ
    @nephromythri
    Oct 23, 2021
    Excellent talk by @hswapnil on Contrast induced acute kidney injury (CI-AKI). Here is a sneakpeek: ๐Ÿ‘€ How do you define CI-AKI ? Here is a new proposal by @hswapnil
    Image
  • user avatar
    Mythri Shankar ๐Ÿ‡ฎ๐Ÿ‡ณ
    @nephromythri
    Apr 29, 2022
    Checkout our short and simple review on SGLT2 inhibitors and CKD @GlomCon pubs. Enjoyed working with @nephrologik @NWiegley ๐Ÿค—!! pubs.glomcon.org/are-you-a-flozโ€ฆ
    Image

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms of Service|Privacy Policy|Cookie Policy|Accessibility|Ads info|ยฉ 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
Advertisement
Advertisement